Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis

Cardiovasc Pathol. 2003 Sep-Oct;12(5):255-62. doi: 10.1016/s1054-8807(03)00077-2.

Abstract

Introduction: Viruses are known to induce apoptosis in their host cells. We studied whether cardiomyocyte apoptosis occurs upon coxsackievirus B3 (CVB3) infection and whether virus-associated apoptosis plays a role in the pathogenesis of experimental myocarditis.

Methods: BALB/c mice were infected with two variants of CVB3 causing either mild or severe myocarditis. Myocardial and serum samples were collected from Day 1 to Day 14 after virus inoculation. Apoptosis was detected in myocardial tissue sections using the terminal transferase-mediated DNA nick end labelling (TUNEL) assay and staining of active caspase 3, and compared with the presence of infectious CVB3 and viral proteins in cardiomyocytes.

Results: Compared with the noninfected control mice, infection with either CVB3 variant resulted in significantly increased cardiomyocyte apoptosis, which peaked on Day 5 after infection. At this time, the average percentages of apoptotic cardiomyocytes were 0.17% (SD 0.04; P=.03) and 0.77% (SD 0.11; P<.01) in mild and severe disease forms, respectively. The amount of apoptosis correlated with titers of infectious CVB3 in the heart muscle. Viral proteins were detected in the TUNEL-positive cells by immunohistochemistry. In the late stages of disease, apoptosis, together with inflammatory infiltrates persisted only in the severe disease form.

Conclusions: CVB3-associated myocardial damage involves cardiomyocyte apoptosis. In the early stages of the disease, it appears to be triggered by viral replication in the cardiomyocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis*
  • Cell Count
  • Disease Models, Animal
  • Enterovirus B, Human / genetics
  • Enterovirus B, Human / growth & development
  • Enterovirus B, Human / pathogenicity*
  • Enterovirus Infections / complications
  • Enterovirus Infections / pathology*
  • Immunoenzyme Techniques
  • In Situ Nick-End Labeling
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Myocarditis / pathology*
  • Myocarditis / virology
  • Myocytes, Cardiac / metabolism
  • Myocytes, Cardiac / pathology*
  • Myocytes, Cardiac / virology
  • RNA, Viral / analysis
  • Viral Plaque Assay
  • Viral Proteins / analysis

Substances

  • RNA, Viral
  • Viral Proteins